Advertisement

Related Videos

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Varsha Gandhi, PhD, on Ibrutinib

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Advertisement

Advertisement




Oct
01
Today In Oncology
Cleveland Clinic London Appoints Oncology Vice Chief
NCCN Models How to Tailor Cancer Care for Different Regions During 2026 World Cancer Congress
IARC Panel Provides International Determination on Lung Cancer Screening Benefits and Harms
Multicancer Early Detection Screening Does Not Reduce Overall Late-Stage Cancer Diagnosis
Can Long Distance Running Be a Risk Factor for Early-Onset Colorectal Cancer?
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo